Loading
A phase 2 trial of Geriatric assessment in Non-Hodgkin lymphoma, run by Fondazione Italiana Linfomi - ETS, now recruiting.
A Combination of Rituximab and CC-99282 as Front-line Therapy for Older Frail Patients With Diffuse Large B-cells Non-Hodgkin Lymphoma Evaluated With a Simplified Geriatric Assessment (sGA): a Phase II Study of the Fondazione Italiana Linfomi (FIL) is a phase 2 interventional study registered as NCT06835530 by Fondazione Italiana Linfomi - ETS, with 47 participants planned, started 2025-04-09 and due to reach its primary completion in 2030-04. Interventions recorded: Rituximab + Golcadomide (CC-99282). Conditions recorded: Diffuse Large B Cell Non-Hodgkin Lymphoma.
Linked to the technology Geriatric assessment because the registry's title names it ("geriatric assessment") and Non-Hodgkin lymphoma among its conditions. Registry record only: no result has been read by an editor.
Shares Fondazione Italiana Linfomi and the tag pipeline.
Shares Geriatric assessment, Non-Hodgkin lymphoma (all types) and the tag pipeline.
Shares Diffuse large B-cell lymphoma, Non-Hodgkin lymphoma (all types) and the tag pipeline.
Shares Diffuse large B-cell lymphoma, Non-Hodgkin lymphoma (all types) and the tag pipeline.
Shares Diffuse large B-cell lymphoma, Non-Hodgkin lymphoma (all types) and the tag pipeline.
Shares Diffuse large B-cell lymphoma, Non-Hodgkin lymphoma (all types) and the tag pipeline.
Shares Golcadomide, Non-Hodgkin lymphoma (all types) and the tag pipeline.
Shares Geriatric assessment and the tag pipeline.